Tag: Betalutin

Mergers and Acquisitions

Nordic Nanovector to merge with APIM after Betalutin fail

November 10, 2022

Via: Pharmaphorum

The merger will create a clinical-stage cancer-focused biotech with funding that will last into 2024 and pipeline headed by ATX-101, a peptide-targeting PCNA being developed by APIM in clinical trials for platinum-sensitive ovarian cancer and sarcoma. Nordic Nanovector was hit […]